Ranking Chemical Structures for Drug Discovery: A New Machine Learning Approach

2010 ◽  
Vol 50 (5) ◽  
pp. 716-731 ◽  
Author(s):  
Shivani Agarwal ◽  
Deepak Dugar ◽  
Shiladitya Sengupta

2021 ◽  
Author(s):  
george chang ◽  
Nathaniel Woody ◽  
Christopher Keefer

Lipophilicity is a fundamental structural property that influences almost every aspect of drug discovery. Within Pfizer, we have two complementary high-throughput screens for measuring lipophilicity as a distribution coefficient (LogD) – a miniaturized shake-flask method (SFLogD) and a chromatographic method (ELogD). The results from these two assays are not the same (see Figure 1), with each assay being applicable or more reliable in particular chemical spaces. In addition to LogD assays, the ability to predict the LogD value for virtual compounds is equally vital. Here we present an in-silico LogD model, applicable to all chemical spaces, based on the integration of the LogD data from both assays. We developed two approaches towards a single LogD model – a Rule-based and a Machine Learning approach. Ultimately, the Machine Learning LogD model was found to be superior to both internally developed and commercial LogD models.<br>



2021 ◽  
Author(s):  
george chang ◽  
Nathaniel Woody ◽  
Christopher Keefer

Lipophilicity is a fundamental structural property that influences almost every aspect of drug discovery. Within Pfizer, we have two complementary high-throughput screens for measuring lipophilicity as a distribution coefficient (LogD) – a miniaturized shake-flask method (SFLogD) and a chromatographic method (ELogD). The results from these two assays are not the same (see Figure 1), with each assay being applicable or more reliable in particular chemical spaces. In addition to LogD assays, the ability to predict the LogD value for virtual compounds is equally vital. Here we present an in-silico LogD model, applicable to all chemical spaces, based on the integration of the LogD data from both assays. We developed two approaches towards a single LogD model – a Rule-based and a Machine Learning approach. Ultimately, the Machine Learning LogD model was found to be superior to both internally developed and commercial LogD models.<br>



2019 ◽  
Author(s):  
Yvette L. Eley ◽  
William Thompson ◽  
Sarah E. Greene ◽  
Ilya Mandel ◽  
Kirsty Edgar ◽  
...  


2021 ◽  
Author(s):  
Amnah Eltahir ◽  
Jason White ◽  
Terry Lohrenz ◽  
P. Read Montague

Abstract Machine learning advances in electrochemical detection have recently produced subsecond and concurrent detection of dopamine and serotonin during perception and action tasks in conscious humans. Here, we present a new machine learning approach to subsecond, concurrent separation of dopamine, norepinephrine, and serotonin. The method exploits a low amplitude burst protocol for the controlled voltage waveform and we demonstrate its efficacy by showing how it separates dopamine-induced signals from norepinephrine induced signals. Previous efforts to deploy electrochemical detection of dopamine in vivo have not separated the dopamine-dependent signal from a norepinephrine-dependent signal. Consequently, this new method can provide new insights into concurrent signaling by these two important neuromodulators.



Author(s):  
Jianjiong Gao ◽  
Ganesh Kumar Agrawal ◽  
Jay J. Thelen ◽  
Zoran Obradovic ◽  
A. Keith Dunker ◽  
...  


2021 ◽  
Author(s):  
Robert I. Horne ◽  
Andrea Possenti ◽  
Sean Chia ◽  
Z. Faidon Brotzakis ◽  
Roxine Staats ◽  
...  

Drug development is an increasingly active area of machine learning application, due to the high attrition rates of conventional drug discovery pipelines. This issue is especially pressing for neurodegenerative diseases where very few disease modifying drugs have been approved, demonstrating a need for novel and efficient approaches to drug discovery in this area. However, whether or not machine learning methods can fulfil this role remains to be demonstrated. To explore this possibility, we describe a machine learning approach to identify specific inhibitors of the proliferation of alpha-synuclein aggregates through secondary nucleation, a process that has been implicated in Parkinson's disease and related synucleinopathies. We use a combination of docking simulations followed by machine learning to first identify initial hit compounds and then explore the chemical space around these compounds. Our results demonstrate that this approach leads to the identification of novel chemical matter with an improved hit rate and potency over conventional similarity search approaches.





2019 ◽  
Author(s):  
Yvette Eley ◽  
◽  
William Thomson ◽  
Sarah E. Greene ◽  
Ilya Mandel ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document